Intrinsiqq

Making Science Group S.A. (MAKS.XMAD) Quality Score

MAKS.XMAD
Quality65

Growth remains strong (avg 100/100), but business quality is pulling the composite down (avg 24/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
100/100
2.2x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
100/100
1.7x

Under 20x cash flow, well covered

Revenue Growth
100/100
18.3%

Above 10% CAGR, strong compounder

Cash Flow Growth
100/100
66.3%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
0/100
10.8%

Heavy dilution above 5%

Margin Trend
0/100
-2.1pp

Contracted >2pp, margin pressure

Capital Structure
95/100
€6M

Net debt/FCF of 0.2x, easily serviceable

2022
€32M
€58M
2023
€20M
€63M
2024
€22M
€57M
2025
€34M
€41M
Return on Capital
0/100
-0.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Making Science Group (MAKS.XMAD) quality: score, margins and returns

Making Science Group (MAKS.XMAD) scores 65/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on -0.1% operating margins and -0.2% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Making Science Group (MAKS.XMAD) a high-quality business?+

Making Science Group scores 65 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a -0.1% operating margin and a -0.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Making Science Group's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from MAKS.XMAD's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Making Science Group scores well and where it falls behind.

What is Making Science Group's return on invested capital (ROIC)?+

Making Science Group earns about -0.2% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to MAKS.XMAD's margins and growth on this scorecard to judge durability.

How profitable is Making Science Group?+

Making Science Group runs an operating margin of about -0.1% and a net margin of about 7.2%. Revenue has grown at roughly 33.3% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on MAKS.XMAD: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Related stocks: Advertising Agencies

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.